Home > Share Market > Stocks > Transgene biotek > Financial Statements> Profit & Loss

Transgene Biotek Ltd Financial Statements

Profit and Loss

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 0.17 -- 0.12 0.28
yoy growth (%) 4,642 (97) (58) 54.70
Raw materials (0.10) -- -- --
As % of sales 35.90 414 41.20 --
Employee costs (0.20) (0.30) (0.30) (0.60)
As % of sales 145 8,098 277 197
Other costs (0.40) (0.60) (1.80) (2.30)
As % of sales 230 15,744 1,562 815
Operating profit (0.50) (0.90) (2.10) (2.60)
OPM (311) (24,156) (1,781) (912)
Depreciation (9.90) (9.90) (9.90) (18)
Interest expense (0.30) (0.40) (1) (0.40)
Other income 0.27 0.18 7.37 0.66
Profit before tax (10) (11) (5.70) (20)
Taxes -- -- (0.80) --
Tax rate -- -- 13.90 --
Minorities and other -- -- -- --
Adj. profit (10) (11) (6.40) (20)
Exceptional items -- -- -- --
Net profit (10) (11) (6.40) (20)
yoy growth (%) (4.80) 70.30 (68) (7.80)
NPM (6,154) (306,602) (5,445) (7,072)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000